Laboratorios Almirall SA -and- Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)

23 January 2009

Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other’s patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held that both patents were invalid and should be revoked.